Related Experiment Video
Updated: Jun 20, 2026

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
Published on: January 22, 2019
Ramucirumab induces apoptosis in Caco-2 cells via mitochondrial impairment and caspase activation
Amal M Al-Dogmi1, Khalid Mashay Al-Anazi1, Wajhul Qamar2
1Department of Zoology, College of Science, King Saud University, P.O. Box 2455, 11451, Riyadh, Saudi Arabia.
Abstract:
Ramucirumab, a monoclonal antibody that targets vascular endothelial growth factor receptor-2 (VEGFR-2), is primarily known for its ability to inhibit angiogenesis in a variety of cancer types. Its direct cytotoxic mechanisms in colorectal cancer cells, especially those related to mitochondrial dysfunction and reactive oxygen species (ROS)-mediated apoptosis, are inadequately elucidated. This work aims to examine the involvement of mitochondrial dysfunction, oxidative stress, and caspase activation in mediating ramucirumab induced cytotoxicity in Caco-2 cells. MTT (3-(4, 5-dimethylthiazolyl-2)-2, 5-diphenyltetrazolium bromide) and lactate dehydrogenase (LDH) tests were used to measure cell viability and cytotoxicity, respectively by exposing Caco-2 cells to ramucirumab for 24 h. Flow cytometry was used to analyze apoptosis and cell cycle distribution. Hoechst 33342, rhodamine 123 and carboxy-H2DCFDA staining was used to examine nuclear condensation, mitochondrial membrane potential (ΔΨm) and intracellular ROS, respectively. Additionally, the expression of the apoptotic markers caspase-3 and caspase-7, and levels of VEGF was quantified. Ramucirumab enhanced the release of LDH, and significantly (p < 0.05) decreased cell viability with increasing concentration and IC50 value was estimated as 780 µg/ ml. A significant (p < 0.05) increase in the apoptotic cell population and cell cycle arrest primarily at the S-phase was observed. Nuclear condensation and fragmentation were observed and mitochondrial membrane potential was found to be decreased, indicating mitochondrial dysfunction. Additionally, oxidative stress (ROS) and VEGF was elevated and cleaved caspase-3 and caspase-7 were significantly upregulated, indicating caspase-mediated apoptosis. In conclusion, by causing cell cycle arrest and inducing apoptosis via mitochondrial malfunction and caspase pathway activation, ramucirumab demonstrates anti-cancer action against Caco-2 cells. These findings provide new perspectives on ramucirumab's wider anti-tumor potential beyond angiogenesis inhibition.
Insights
Ramucirumab induces colorectal cancer cell death by triggering apoptosis through mitochondrial dysfunction and caspase activation, revealing anti-cancer effects beyond angiogenesis inhibition.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Ramucirumab, a VEGFR-2 inhibitor, is known for anti-angiogenesis effects in various cancers.
- Direct cytotoxic mechanisms of ramucirumab in colorectal cancer, particularly involving mitochondrial dysfunction and ROS-mediated apoptosis, require further elucidation.
Purpose of the Study:
- To investigate the role of mitochondrial dysfunction, oxidative stress, and caspase activation in ramucirumab-induced cytotoxicity in Caco-2 colorectal cancer cells.
Main Methods:
- Cell viability (MTT) and cytotoxicity (LDH) assays were performed.
- Flow cytometry analyzed apoptosis and cell cycle distribution.
- Staining assessed nuclear condensation, mitochondrial membrane potential (ΔΨm), and intracellular reactive oxygen species (ROS).
- Expression of caspase-3, caspase-7, and VEGF levels were quantified.
Main Results:
- Ramucirumab decreased Caco-2 cell viability (IC50 = 780 µg/ml) and increased LDH release.
- Apoptosis significantly increased, with cell cycle arrest observed primarily in the S-phase.
- Mitochondrial dysfunction (decreased ΔΨm), elevated ROS, and increased VEGF were noted.
- Caspase-3 and caspase-7 activation indicated caspase-mediated apoptosis.
Conclusions:
- Ramucirumab exhibits anti-cancer activity against Caco-2 cells by inducing cell cycle arrest and apoptosis.
- The mechanism involves mitochondrial dysfunction and activation of the caspase pathway.
- These findings suggest broader anti-tumor potential for ramucirumab beyond its anti-angiogenic properties.
Related Concept Videos
Caspases
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Apoptosis
Cellular Injury V: Apoptosis and Autophagy
